In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies-Reference-Cited by-同舟云学术

In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies

Published:2024-09 Issue:1 Volume:110 Page:116372
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Amadesi Stefano,Amedeo Alberto,Rinaldi Matteo,Palombo Marta,Giannella Maddalena,Gaibani Paolo^ORCID

Funder

Ministero della Salute

Publisher

Elsevier BV

Reference11 articles.

1. Carbapenem-Resistant Enterobacteriaceae;Iovleva;Clin Lab Med,2017

2. Cefiderocol: A siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli;Zhanel;Drugs,2019

3. Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient;Gaibani;J Glob Antimicrob Resist,2022

4. Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC β-lactamase mutants and the inoculum effect;Hobson;Clin Microbiol Infect,2021

5. The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate;Birgy;Antimicrob Agents Chemother,2024

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations Leading to Ceftolozane/Tazobactam and Imipenem/Cilastatin/Relebactam Resistance Duringin vivoexposure to Ceftazidime/Avibactam inPseudomonas aeruginosa;2024-09-10